Lemaitre Vascular Inc (LMAT) — 8-K Filings

8-K Filings (16)

• Lemaître Vascular Appoints New CFO, Stock Grants — Apr 14, 2026 Risk: medium
  On April 8, 2026, Lemaître Vascular, Inc. announced the appointment of David L. Roberts as Chief Financial Officer, effective April 15, 2026. Roberts will recei
• LeMaitre Vascular Files 8-K Report — Nov 6, 2025 Risk: low
  On November 6, 2025, LeMaitre Vascular, Inc. filed an 8-K report. The filing indicates no new material events or financial updates requiring immediate disclosur
• LeMaitre Vascular Files 8-K on Financials — Aug 5, 2025 Risk: low
  On August 5, 2025, LeMaitre Vascular, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as we
• LeMaitre Vascular Files 8-K on Shareholder Vote Matters — Jun 3, 2025 Risk: low
  On June 2, 2025, LeMaitre Vascular, Inc. filed an 8-K report indicating that it is submitting matters to a vote of its security holders. The filing was made on
• LeMaitre Vascular Files 8-K on Financials — May 1, 2025 Risk: low
  LeMaitre Vascular, Inc. filed an 8-K on May 1, 2025, reporting on its results of operations and financial condition. The filing includes financial statements an
• LeMaitre Vascular Files 8-K on Financials — Feb 27, 2025 Risk: low
  On February 27, 2025, LeMaitre Vascular, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as
• LeMaitre Vascular Appoints New Director, Officer Comp Details — Feb 13, 2025 Risk: low
  On February 7, 2025, LeMaitre Vascular, Inc. filed an 8-K report detailing the departure of Director David M. D’Amato and the appointment of Dr. David E. Astion
• LeMaitre Vascular Files 8-K: Material Agreement & Equity Sales — Dec 19, 2024 Risk: medium
  On December 16, 2024, LeMaitre Vascular, Inc. entered into a material definitive agreement, creating a direct financial obligation. The company also reported on
• LeMaitre Vascular Files 8-K Report — Dec 17, 2024 Risk: low
  On December 16, 2024, LeMaitre Vascular, Inc. filed an 8-K report to disclose information under Regulation FD. The filing includes financial statements and exhi
• LeMaitre Vascular Files 8-K for Reg FD Disclosure — Dec 16, 2024 Risk: low
  On December 16, 2024, LeMaitre Vascular, Inc. filed an 8-K report. The filing primarily serves as a notification of a Regulation FD Disclosure and the filing of
• LeMaitre Vascular Files 8-K on Financials — Oct 31, 2024 Risk: low
  LeMaitre Vascular, Inc. filed an 8-K on October 31, 2024, reporting on its results of operations and financial condition. The filing includes financial statemen
• LeMaitre Vascular Files 8-K on Director Changes — Aug 26, 2024 Risk: medium
  On August 26, 2024, LeMaitre Vascular, Inc. filed an 8-K report detailing changes in its board of directors and executive compensation. The filing indicates the
• LeMaitre Vascular Files 8-K on Operations and Financials — Aug 1, 2024 Risk: low
  On August 1, 2024, LeMaitre Vascular, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as we
• LeMaitre Vascular Files 8-K: Director Changes & Officer Comp Updates — Jun 3, 2024 Risk: low
  On June 3, 2024, LeMaitre Vascular, Inc. filed an 8-K report detailing several key events. These include the departure of a director, the election of a new dire
• LeMaitre Vascular Files 8-K on Financials — May 2, 2024 Risk: low
  On May 2, 2024, LeMaitre Vascular, Inc. filed an 8-K report. The filing primarily concerns the company's financial condition and results of operations, with no
• LeMaitre Vascular Files 8-K on Financial Results — Feb 27, 2024 Risk: low
  LeMaitre Vascular, Inc. (CIK: 0001158895) filed an 8-K on February 27, 2024, reporting on its "Results of Operations and Financial Condition" and "Financial Sta

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX